Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Guilford Pharmaceuticals Inc (GLFD) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Guilford Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 918066.
Total stock buying since 2005: $364,148.
Total stock sales since 2005: $0.
Total stock option exercises since 2005: $0.
▪ Recent SEC 13D filings for all companies
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2005-04 | 167,625 | $364,148 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2005-04-11 | Greetham Elizabeth M (Director) | Buy | 10,000 | 2.14 | 21,400 |
| 2005-04-08 | Spengler William (Exec. VP and CFO) | Buy | 11,375 | 2.18 | 24,797 |
| 2005-04-08 | Mitchell Dean J (President and C.E.O.) | Buy | 54,250 | 2.17 | 117,722 |
| 2005-04-07 | Uprichard David C (Director) | Buy | 2,000 | 2.24 | 4,480 |
| 2005-04-07 | Snyder Solomon H Md (Director) | Buy | 90,000 | 2.17 | 195,749 |
Insider trading activities including stock purchases, stock sales, and option exercises of GLFD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Guilford Pharmaceuticals Inc (symbol GLFD, CIK number 918066) see the Securities and Exchange Commission (SEC) website.